Kaletra and T-cell prolymphocytic leukaemia - from FDA reports


Summary

There is no T-cell prolymphocytic leukaemia reported by people who take Kaletra yet. This review analyzes which people have T-cell prolymphocytic leukaemia with Kaletra. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Kaletra and have T-cell prolymphocytic leukaemia, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Kaletra and have T-cell prolymphocytic leukaemia

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 18, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have T-cell prolymphocytic leukaemia when taking Kaletra?

Expand the study to include all drugs with the same ingredients

T-cell prolymphocytic leukaemia and drugs with ingredients of lopinavir; ritonavir.

Expand the study to include reports from both FDA and eHealthMe

T-cell prolymphocytic leukaemia and Kaletra from FDA and eHealthMe reports

Kaletra

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. (latest outcomes from Kaletra 17,412 users)

T-cell Prolymphocytic Leukaemia

T-cell prolymphocytic leukaemia (a aggressive type of t cell cancer) has been reported by people with t-cell prolymphocytic leukaemia, breast cancer, preventive health care, stem cell transplant, crohn's disease (latest reports from 173 T-cell prolymphocytic leukaemia patients).

Browse all side effects of Kaletra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with T-cell prolymphocytic leukaemia

T-cell prolymphocytic leukaemia

Could your condition cause T-cell prolymphocytic leukaemia

T-cell prolymphocytic leukaemia

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Kaletra and have T-cell prolymphocytic leukaemia.

Questions to the study

More questions >

User reviews to the study

More reviews >